|
Selvita participates in the 2010 BIO International Convention |
Place: 3rd - 6th May 2010, McCormick Place, Chicago, USA
BIO International Convention is the largest global event for the biotechnology industry, attracting the biggest names in biotech. This annual event offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
To request a meeting with a representative of Selvita at the 2010 BIO Convention please kindly send an e-mail to
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Find out more about BIO International Convention in Chicago. |
|
|
Selvita participates in the European Business Development Conference 2010 |
Place: 14th-15th June 2010, Hotel Vier Jahreszeiten Kempinski, Munich, Germany
The 2010 edition of the European Business Development Conference is organized by BIO Deutschland under the theme of "Powering Relationships Between the Pharmaceutical Industrie and European Biotechs".
The European Biopharmaceutical Enterprises (EBE) is the European partner for the conference. In addition, the conference is supported by the UK's BioIndustry Association (BIA) and the Spanish Association of Bioenterprises (ASEBIO).
The conference aims to bring together a select group of 120 business development executives from international pharmaceutical corporations and European biotech companies, with representatives from private equity and venture capital companies. The two-day programme includes opportunities for business networking, company presentations, and panel discussions with decision makers from international pharmaceutical corporations, European biotechnology companies, and investors. Emphasis will be placed on bringing companies together and supporting partnerships.
We cordially invite you to attend Selvita's presentation during this conference.
To arrange a meeting with Selvita's delegate, please contact us at:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
|
|
Selvita Releases New Molecular Modeling Software for Life Science Researchers |
Selvita releases its breakthrough protein structure prediction and protein-protein docking package for life science researchers with Selvita Protein Modeling Platform 2.0
Krakow, October 5, 2009 -- Selvita, a privately-held provider of products and services for biotechnology industry, today announced the release of Selvita Protein Modeling Platform 2.0 (SPMP 2.0), the latest version of its flagship protein discovery research software. This release features a new protein-protein docking module, usability enhancements, and improves discovery results for its users. SPMP 2.0 provides the necessary set of tools for protein structure and interactions modeling in web-based interface adapted for both beginner and expert users’ needs.
Dr. Nicolas Beuzen, Selvita’s Chief Scientific Officer, announced the new version release, saying: “For this major update of Selvita Protein Modeling Platform, our team of experts has been working at adding an unparalleled protein-protein docking module to the unique feature set of SPMP. This most important customer-requested enhancement completes our software offer in protein structure modeling. The core feature of the docking approach is to introduce a substantial degree of protein backbone flexibility during docking. Our technology allows users to predict protein-protein interactions on an unprecedented scale, surpassing previously available solutions in comparative benchmark studies. We have also improved our loop modeling and molecular mechanics optimization protocols together with 3D visualization functionalities and web-interface usability. Starting with homology modeling, broad range of tools, and together with unique structure prediction from sequence only and protein docking capabilities, SPMP 2.0 allows researchers to obtain comparative views of the protein structure and interactions data that they want to understand”.
“Protein structure predictive modeling is already advancing drug design by providing invaluable information on structure of protein-protein complexes” added Dr. Beuzen. “Antibodies are among the most promising drugs of the future. Selvita Protein Modeling Platform 2.0 will help scientists design and analyze new antibody-based drugs candidates with unmatched precision"
The key concept behind the Modeling Platform is the integration of state-of-the-art bioinformatics tools in a user-friendly web application, thus ensuring portability and interoperability among systems. Selvita Protein Modeling Platform 2.0 contains a robust core of unique structure prediction tools with high scientific credibility gained by its core algorithms in academic environment. Additional SPMP 2.0 components allow enhanced visualization capability, comparison of molecular models, sequence and structural analysis tailored to accelerate and simplify the discovery process.
The key modules of SPMP are:
- homology modeling , providing a complete procedure for structure prediction based on homologous structures, starting from sequence only;
- protein-protein docking, catering for a complete docking module including rigid-body docking, optional structural filtering according to user-provided data on interface residues and fully flexible docking approach;
- loop modeling , including loop structure prediction module from sequence only;
- de novo modeling for structure prediction module from sequence only.
For more information about the Selvita Protein Modeling Platform 2.0 please visit http://www.selvita.com/selvita-protein-modeling-platform.html
or contact Selvita at
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
About Selvita:
Selvita delivers comprehensive solutions to customers from the pharmaceutical and biotechnology industry targeted at lowering the cost of introducing innovative compounds to the market. The areas of our activity include: advanced protein modeling services and software; computer aided drug design; optimization of lead compounds; contract synthesis; information technology for research projects.
Selvita also develops its own research projects on innovative drugs up to the pre-clinical stage.
Contact:
Natalia Pawela
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
+48 12 6645305 |
|
|
Selvita participates in the Drug Discovery Outsourcing conference |
Place: 9th June 2010, SCI HQ, London, UK
Selvita participates in the Drug Discovery Outsourcing conference which is targeted at companies involved in Drug Discovery Outsourcing, including companies offering services within the drug discovery field, as well as these considering outsourcing as an option. This event will combine a discussion of both day to day practicalities, as well as key strategic insights.
Selvita will exhibit during this conference, therefore we cordially invite you to visit us at our stand. To arrange a meeting with Selvita's delegate at this conference, please contact us at:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
|
|
Selvita participates in the 3rd International Conference on Enhanced Solubility and Bioavailability |
Place: 22nd - 24th February 2010, Dorint Pallas, Wiesbaden, Germany.
This conference offers participants to gain insight into the most recent tools allowing to understand chemical structure, solid state forms and formulation techniques, leading to a better solubility and bioavailability of substances. Main topics of this conference include: comparison of liquid, nanoparticles, co-crystals and amorphous concepts to ensure bioavailability, implementation of new test methods for solubility to speed up development and many more.
This event also provides an opportunity to meet the greatest experts from the industry who will report on their first-hand experiences and the latest developments.
Selvita will also participate in the Workshop day on the 24th February, in the following two sessions:
Workshop A: "Strategies to enhance solubility of compounds"
Workshop D: "Amorphous materials for optimised drug performance"
To arrange a meeting with Selvita's delegate at this conference please contact:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
|
|
